Login to Pancreatic Cancer UK

Clinical Pioneer Awards

Clinical Pioneer Awards Web Banner Plus Text

Pancreatic Cancer UK Clinical Pioneer Awards

The Clinical Pioneer Awards scheme is a new way of funding for Pancreatic Cancer UK. The scheme was set up because the Charity wanted to have the flexibility to support research into issues and priority areas that affect patients and carers currently living with pancreatic cancer as well as research into practical interventions to tackle earlier diagnosis.

The Clinical Pioneers Award Scheme is an opportunity for clinicians and non-clinicians (for example qualitative research academics or technology developers) who have innovative project ideas that are focused on interventions within the clinical or community setting to improve diagnosis, treatment and care, quality of life or experience for pancreatic cancer patients or carers to receive funding. It responds to the fact that these types of projects might find it difficult to receive funding through existing funding streams. It is hoped some of these interventions will also have an impact on patient outcomes.

Under the Clinical Pioneer Awards scheme, funding is awarded to projects that address one of five key priority areas, as identified and ranked by a group of Pancreatic Cancer UK’s key stakeholders. Applicants are asked to demonstrate how their application would target one of these areas:

  • Awareness raising
  • Early and rapid diagnosis
  • Promoting quality of life
  • Treatment and survival
  • Supportive care.

All applications for funding are subject to a rigorous review process to identify proposals with the best chances of making a difference to people affected by pancreatic cancer. A final funding recommendation is made by our Medical Advisory Board.

Key dates:

We are not currently offering the Clinical Pioneer Awards, but for information on the next call please see contact details at the bottom of this page. Examples of guidance for previous rounds is also available below.

Enquiries

For any queries relating to this fund, please email or call the research team on 020 7820 6705.

Useful documents